GT
AGRX

Glenmede Trust’s Agile Therapeutics AGRX Stock Holding History

Glenmede Trust’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5
Closed -$41K – 2836
2017
Q3 		$41K Hold
5
– – ﹤0.01% 1721
2017
Q2 		$29K Hold
5
– – ﹤0.01% 1803
2017
Q1 		$29K Hold
5
– – ﹤0.01% 1803
2016
Q4 		$53K Hold
5
– – ﹤0.01% 1590
2016
Q3 		$65K Hold
5
– – ﹤0.01% 1526
2016
Q2 		$70K Buy
+5
New +$68.5K ﹤0.01% 1460

Other funds holding AGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return